Covishield produces more antibodies with higher seropositivity rate than Covaxin: Preliminary study

A preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) has stated Covishield vaccine produced more antibodies than Covaxin. The study, involving healthcare workers (HCW) who have received both doses of either of the two vaccines, also said seropositivity rates to anti-spike antibody were significantly higher in Covishield recipients as compared to Covaxin after the first dose.

from IndiaTV India: Google News Feed

Get Breaking news, Live news, and latest news from India and around the world on, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News